{"address1": "802 West Bay Road", "address2": "Grand Pavilion Hibiscus Way PO Box 31119", "city": "George Town", "zip": "KY1-1205", "country": "Cayman Islands", "website": "https://www.tanvex.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Tanvex BioPharma, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar in Taiwan and the United States. The company focuses on delivering biosimilars which target neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis. Its products pipeline includes TX01 and TX-05 which have completed Phase III clinical trials; TX-04 and TX-16 that are in Phase I clinical trial; and TX-52 and other products which are in pre-clinical trial. The company was formerly known as Ruenvex Biotech, Inc. Tanvex BioPharma, Inc. was incorporated in 2013 and is based in George Town, the Cayman Islands.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Yun  Yen F.A.C.P., FACP, M.D., Ph.D.", "age": 67, "title": "Chairman, Pres & CEO", "yearBorn": 1955, "fiscalYear": 2021, "totalPay": 15000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. K. H. Lin", "title": "CFO & Corp. Controller", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Val  Chen", "title": "Director of Operation Management & Corp. Governance Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ken  Huang", "title": "Accounting Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Zheng  Xia", "title": "Chief Technology Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Linda  Grillo", "title": "Director of Sales & Marketing", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Hsun-Chiang  Hsieh", "title": "Sec.", "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400, "priceHint": 2, "previousClose": 79.6, "open": 79.6, "dayLow": 75.5, "dayHigh": 79.9, "regularMarketPreviousClose": 79.6, "regularMarketOpen": 79.6, "regularMarketDayLow": 75.5, "regularMarketDayHigh": 79.9, "payoutRatio": 0.0, "beta": 0.630573, "forwardPE": -20.80214, "volume": 247486, "regularMarketVolume": 247486, "averageVolume": 472365, "averageVolume10days": 195591, "averageDailyVolume10Day": 195591, "bid": 77.5, "ask": 77.8, "bidSize": 0, "askSize": 0, "marketCap": 9340357632, "fiftyTwoWeekLow": 75.0, "fiftyTwoWeekHigh": 219.73927, "priceToSalesTrailing12Months": 416.9058, "fiftyDayAverage": 102.73124, "twoHundredDayAverage": 124.46131, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "TWD", "enterpriseValue": 10417131520, "profitMargins": 0.0, "floatShares": 61632670, "sharesOutstanding": 120056000, "heldPercentInsiders": 0.53733003, "heldPercentInstitutions": 0.04034, "impliedSharesOutstanding": 0, "bookValue": 11.828, "priceToBook": 6.577613, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1672444800, "netIncomeToCommon": -1641129984, "trailingEps": -13.71, "forwardEps": -3.74, "lastSplitFactor": "333:1000", "lastSplitDate": 1677715200, "enterpriseToRevenue": 464.967, "enterpriseToEbitda": -6.981, "52WeekChange": -0.5522752, "SandP52WeekChange": -0.033239067, "exchange": "TAI", "quoteType": "EQUITY", "symbol": "6541.TW", "underlyingSymbol": "6541.TW", "shortName": "TANVEX BIOPHARMA INC", "longName": "Tanvex BioPharma, Inc.", "firstTradeDateEpochUtc": 1439427600, "timeZoneFullName": "Asia/Taipei", "timeZoneShortName": "CST", "uuid": "380b0414-7367-3e8a-b14f-67cf4f0831a1", "messageBoardId": "finmb_306254596", "gmtOffSetMilliseconds": 28800000, "currentPrice": 77.8, "recommendationMean": 2.0, "recommendationKey": "buy", "totalCash": 786233024, "totalCashPerShare": 6.683, "ebitda": -1492299008, "totalDebt": 1839235968, "quickRatio": 2.684, "currentRatio": 3.441, "totalRevenue": 22404000, "debtToEquity": 132.178, "revenuePerShare": 0.191, "returnOnAssets": -0.24675, "returnOnEquity": -0.78405, "grossProfits": -19348000, "freeCashflow": -844233152, "operatingCashflow": -1333847040, "revenueGrowth": 0.632, "grossMargins": -0.86359, "ebitdaMargins": 0.0, "operatingMargins": -71.66207, "financialCurrency": "TWD", "trailingPegRatio": null}